Swedish private equity giant EQT() is expanding its footprint in the European healthcare venture capital sector after entering into an agreement to acquire Life Sciences Partners (LSP) in a deal valued at up to €475 million.
The deal calls for an upfront payment of €450 million, of which 25% would be cash and the remainder consisting of publicly traded EQT shares. An additional earn-out payment of €25 million is in the cards if undisclosed fundraising targets are met in the short term. In exchange, EQT will take control of 100% of the LSP management company and . . .
Unlock this article instantly, along with the rest of our premium content and daily, weekly and monthly newsletters. We offer pay-as-you-go monthly subscriptions and discounted annual subscriptions with additional benefits: access to Alternatives Watch Research articles and our Annual Investor Compendium.